Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 246,899	$ 504,389
Restricted cash	1,444	3,345
Investments	179,959	3,212
Trade receivables	42,610	29,413
Inventory	27,019	15,791
Prepaid expenses and other current assets	11,070	9,986
Total current assets	509,001	566,136
Property and equipment, net	8,464	8,714
Long-term investments	34,332	6,829
Other assets	6,797	6,472
Total assets	558,594	588,151
Liabilities and Stockholders’ Deficit
Accounts payable	8,622	27,808
Accrued expenses	69,265	72,670
Deferred revenue	1,554	1,421
Lease financing obligation	2,196	1,819
Total current liabilities	81,637	103,718
Lease financing obligation	5,968	5,962
Royalty financing obligations	489,781	449,375
Secured term loan	223,867	136,082
Stockholders’ equity:
Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding	0	0
Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 186,411 as of September 30, 2022 and 184,350 as of December 31, 2021	1,864	1,843
Additional paid-in capital	1,138,654	1,098,498
Accumulated other comprehensive (loss) income	(98)	177
Accumulated deficit	(1,383,079)	(1,207,504)
Total stockholders’ deficit	(242,659)	(106,986)
Total liabilities and stockholders’ deficit	$ 558,594	$ 588,151